BOSTON – Troutman Pepper Locke represented Cardiol Therapeutics Inc. (NASDAQ: CRDL; TSX: CRDL), as agent, in connection with its private placement of units at a price of C$1.30 per unit for aggregate gross proceeds of C$14.85 million. For more information, see the press release.
Cardiol Therapeutics intends to use the net proceeds of the financing to advance its research and clinical development programs and for general and administrative expenses, working capital, and other expenses.
The Troutman Pepper Locke team that advised Cardiol Therapeutics included Tom Rose, Shona Smith, Lisa Reidy, Jacob Richards, and Codi Royall.
Consistently recognized as a top-tier practice, Troutman Pepper Locke’s corporate attorneys regularly handle strategic deals for clients ranging from industry-leading, Fortune 100 corporations to emerging companies. Core areas of service include mergers and acquisitions, corporate finance, corporate governance, securities laws compliance, capital markets transactions, and other significant domestic and cross-border transactions, as well as general corporate counseling.
Troutman Pepper Locke
Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.